B75956
4-Bromphenylboronsäure
≥95.0%
Synonym(e):
4-Brom-benzolboronsäure
Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)
About This Item
Lineare Formel:
BrC6H4B(OH)2
CAS-Nummer:
Molekulargewicht:
200.83
Beilstein:
2936347
EG-Nummer:
MDL-Nummer:
UNSPSC-Code:
12352103
PubChem Substanz-ID:
NACRES:
NA.22
Empfohlene Produkte
![[Pd(OAc)2]3 reagent grade, 98%](/deepweb/assets/sigmaaldrich/product/structures/508/249/99a0ef2c-b77c-4d73-8ed9-0cca05b6b41f/640/99a0ef2c-b77c-4d73-8ed9-0cca05b6b41f.png)
Qualitätsniveau
Assay
≥95.0%
95%
Form
crystals
mp (Schmelzpunkt)
284-288 °C (lit.)
SMILES String
OB(O)c1ccc(Br)cc1
InChI
1S/C6H6BBrO2/c8-6-3-1-5(2-4-6)7(9)10/h1-4,9-10H
InChIKey
QBLFZIBJXUQVRF-UHFFFAOYSA-N
Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich
Anwendung
Reagent used for
Reagent used in Preparation of
- Palladium catalyzed Suzuki-Miyaura cross-couplings
- Pd(II)-catalyzed diastereoselective conjugate additions
- Palladium-catalyzed stereoselective Heck-type reaction of allylic esters with arylboronic acids
- Tandem-type Pd(II)-catalyzed oxidative Heck reaction and intramolecular C-H amidation sequence
- Copper-mediated ligandless aerobic fluoroalkylation of arylboronic acids with fluoroalkyl iodides
- Pd-catalyzed arylative cyclization of alkyne-tethered enals or enones via carbopalladation of alkynes
- Copper-catalyzed cross-couplings
Reagent used in Preparation of
- Gallate-based obovatol analogs with potential anti-tumor activity
- Protein modulators and enzymatic and kinase inhibitors
Sonstige Hinweise
enthält schwankende Anteile Anhydrid
Signalwort
Warning
H-Sätze
Gefahreneinstufungen
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
Zielorgane
Respiratory system
Lagerklassenschlüssel
11 - Combustible Solids
WGK
WGK 3
Persönliche Schutzausrüstung
dust mask type N95 (US), Eyeshields, Gloves
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
Kunden haben sich ebenfalls angesehen
Erin Tay et al.
Pharmaceutics, 12(1) (2019-12-28)
Lipid based formulations (LBFs) are commonly employed to enhance the absorption of highly lipophilic, poorly water-soluble drugs. However, the utility of LBFs can be limited by low drug solubility in the formulation. Isolation of ionizable drugs as low melting, lipophilic
Chuan Xiao et al.
Bioorganic & medicinal chemistry, 19(23), 7100-7110 (2011-11-01)
A series of purine nucleoside analogues bearing an aryl and hetaryl group in position 6 were prepared and their biological activities were assessed by in vitro CDK1/Cyclin B1 and CDK2/Cyclin A2 kinase assay. From the synthesized chemicals, three Xylocydine derivatives
Xing Li et al.
Organic & biomolecular chemistry, 10(3), 495-497 (2011-11-22)
Suzuki-Miyaura cross-couplings of arenediazonium salts with arylboronic acids catalyzed by highly active aluminium hydroxide-supported palladium nanoparticles catalyst have been investigated for the first time. The reactions are performed at 25 °C in MeOH without any base and ligand to afford
Anna C Pham et al.
Journal of controlled release : official journal of the Controlled Release Society, 268, 400-406 (2017-11-04)
Phosphorylated tocopherols are a new class of lipid excipients that have demonstrated potential in pharmaceutical applications. Their ability to solubilise poorly water soluble drugs indicates their potential utility in improving bioavailability of drugs where solubility limits their bioavailability. In this
Synthesis of obovatol derivatives and their preliminary evaluation as antitumor agents
Lee, M.-S.; et al.
Bull. Korean Chem. Soc., 28, 1601-1604 (2007)
Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..
Setzen Sie sich mit dem technischen Dienst in Verbindung.